SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-253620
Filing Date
2019-09-24
Accepted
2019-09-24 16:37:02
Documents
4
Period of Report
2019-09-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d786730d8k.htm 8-K 17354
2 EX-99.1 d786730dex991.htm EX-99.1 9720
3 GRAPHIC g786730g0924213413975.jpg GRAPHIC 631
4 GRAPHIC g786730g0924213414240.jpg GRAPHIC 3890
  Complete submission text file 0001193125-19-253620.txt   34983
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 191111203
SIC: 2834 Pharmaceutical Preparations